Spotlight on pembrolizumab in the treatment of advanced melanoma
Thanashan Rajakulendran,1 David N Adam2 1Department of Medicine, Division of Dermatology, Postgraduate Medical Education, 2Department of Medicine, Division of Dermatology, St Michael’s Hospital, University of Toronto, Toronto, ON, Canada Abstract: Metastatic melanoma is an aggress...
Saved in:
Main Authors: | Rajakulendran T (Author), Adam DN (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness analysis of pembrolizumab versus targeted therapies in advanced melanoma
by: E. G. Kosolapov, et al.
Published: (2018) -
Vitiligo Repigmentation with Melanoma Progression During Pembrolizumab Treatment
by: Charlée Nardin, et al.
Published: (2019) -
Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
by: Pearre DC, et al.
Published: (2018) -
Coincident Metastatic Melanoma and Merkel Cell Carcinoma with Complete Remission on Treatment with Pembrolizumab
by: Alexander Thiem, et al.
Published: (2017) -
Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
by: Anna L. Cogen, MD, PhD, et al.
Published: (2018)